Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -A$0.82 Billion

According to Galapagos NV's latest financial reports the company's current earnings are A$0.32 Billion. In 2024 the company made an earning of -A$8.7 Million, an increase over its 2023 earnings that were of -A$50.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.82 Billion9320.08%
2024 -A$8.7 Million-82.77%
2023 -A$50.5 Million-85.59%
2022 -A$0.36 Billion60.71%
2021 -A$0.22 Billion-60.08%
2020 -A$0.55 Billion-331.44%
2019 A$0.23 B-523.76%
2018 -A$55.71 Million-72.34%
2017 -A$0.21 Billion-329.59%
2016 A$87.73 M-144.3%
2015 -A$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
A$19.70 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$48.77 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.70 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$2.49 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-A$0.14 Billion-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.25 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.66 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$14.03 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$34.76 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA